当前位置:首页 - 行情中心 - 山河药辅(300452) - 财务分析 - 现金流量表

山河药辅

(300452)

  

流通市值:24.83亿  总市值:31.16亿
流通股本:1.87亿   总股本:2.34亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金412,657,246.92186,036,478.39783,036,302.36549,398,385.38
  收到的税费返还10,786,221.13266,731.755,189,508.841,343,414.48
  收到其他与经营活动有关的现金6,321,771.984,875,112.710,321,986.247,642,620.81
  经营活动现金流入小计429,765,240.03191,178,322.84798,547,797.44558,384,420.67
  购买商品、接受劳务支付的现金225,474,534.91135,432,066.85458,740,630.28371,176,213.4
  支付给职工以及为职工支付的现金62,243,071.1434,515,961.4110,224,859.5583,457,090.47
  支付的各项税费39,464,155.3915,298,734.0863,904,826.9744,580,190.98
  支付其他与经营活动有关的现金22,303,016.6612,339,402.0247,344,811.4134,478,150.15
  经营活动现金流出小计349,484,778.1197,586,164.35680,215,128.21533,691,645
  经营活动产生的现金流量净额80,280,461.93-6,407,841.51118,332,669.2324,692,775.67
二、投资活动产生的现金流量:
  收回投资收到的现金360,000,000205,000,000747,000,000593,000,000
  取得投资收益收到的现金6,322,959.142,625,527.6919,383,591.6621,252,376.37
  处置固定资产、无形资产和其他长期资产收回的现金净额397,827361,636546,083.21248,230
  投资活动现金流入小计366,720,786.14207,987,163.69766,929,674.87614,500,606.37
  购建固定资产、无形资产和其他长期资产支付的现金19,472,377.5112,910,768.627,940,912.3319,753,532.57
  投资支付的现金365,010,000165,000,000754,000,000579,000,000
  投资活动现金流出小计384,482,377.51177,910,768.6781,940,912.33598,753,532.57
  投资活动产生的现金流量净额-17,761,591.3730,076,395.09-15,011,237.4615,747,073.8
三、筹资活动产生的现金流量:
  取得借款收到的现金13,020,00013,010,00032,222,60029,222,600
  收到其他与筹资活动有关的现金--14,852,707.17,500,000
  筹资活动现金流入小计13,020,00013,010,00047,075,307.136,722,600
  偿还债务支付的现金15,232,6009,232,60050,506,83118,900,000
  分配股利、利润或偿付利息支付的现金71,351,537.7827,104.3159,007,525.3663,398,940.16
  支付其他与筹资活动有关的现金--22,769,786.3130,016,828.89
  筹资活动现金流出小计86,584,137.789,259,704.31132,284,142.67112,315,769.05
  筹资活动产生的现金流量净额-73,564,137.783,750,295.69-85,208,835.57-75,593,169.05
四、汇率变动对现金及现金等价物的影响859,951.2855,158.381,219,068.67651,868.47
五、现金及现金等价物净增加额-10,185,315.9427,474,007.6519,331,664.87-34,501,451.11
  加:期初现金及现金等价物余额169,511,484.7169,511,484.7150,179,819.83150,179,819.83
  期末现金及现金等价物余额159,326,168.76196,985,492.35169,511,484.7115,678,368.72
补充资料:
  净利润93,234,763.55-120,524,953.63-
  资产减值准备12,701.9-39,124,159.21-
  固定资产和投资性房地产折旧25,595,264.23-49,447,153.27-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,595,264.23-49,447,153.27-
  无形资产摊销705,624.94-1,299,742.16-
  长期待摊费用摊销358,640.64-423,277.62-
  处置固定资产、无形资产和其他长期资产的损失296,889.16--109,338.5-
  固定资产报废损失2,012.49-4,631.53-
  公允价值变动损失-2,367,019.33-3,134,923.69-
  财务费用5,466,437.18-10,856,127.68-
  投资损失-6,322,959.14--19,383,591.66-
  递延所得税2,711,291.74-7,451,595.02-
  其中:递延所得税资产减少13,483.28-15,284.14-
    递延所得税负债增加2,697,808.46-7,436,310.88-
  存货的减少-68,834.9-5,344,982.46-
  经营性应收项目的减少-26,207,168.38--96,588,008.92-
  经营性应付项目的增加-9,565,283.11--3,267,393.32-
  其他-3,571,899.04-69,455.36-
  现金的期末余额159,326,168.76-169,511,484.7-
  减:现金的期初余额169,511,484.7-150,179,819.83-
  现金及现金等价物的净增加额-10,185,315.94-19,331,664.87-
公告日期2025-08-272025-04-232025-04-232024-10-23
审计意见(境内)标准无保留意见
TOP↑